sexual health

Global pharmaceutical company, Mylan, is joining in the battle to prevent HIV infection by delivering the world’s biggest pre-exposure prophylaxis (PrEP) implementation trial, which will target an estimated 10,000 high risk people. Read more


PrEP drugs

A three-year trial of the pre-exposure prophylaxis (PrEP) for the prevention of HIV infection has been announced by NHS England and will be the largest single study of its type in the world with an estimated 10,000 people expected to be included. Read more